Yunnan Baiyao Group
Yunnan Baiyao Group Co Ltd is a major Chinese pharmaceutical and traditional Chinese medicine enterprise headquartered in Kunming, Yunnan Province, China. The company specializes in the research, development, manufacturing, and distribution of proprietary traditional Chinese medicines, modern prescription pharmaceuticals, healthcare products, and personal care items. Principal revenue is generated through wholesale manufacturing sales of pharmaceutical and personal care products to pharmacies, hospitals, and distributors. Yunnan Baiyao Group is publicly listed on the Shenzhen Stock Exchange.
4 of the funds FundTelligence covers report a position in Yunnan Baiyao Group.
- Legal name
- Yunnan Baiyao Group Co Ltd
- Sector
- Health Care
- Country
- China
- Funds holding it
- 4
Funds holding Yunnan Baiyao Group
- Handelsbanken Emerging Markets Index — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Handelsbanken Global Index Criteria — Handelsbanken · 0.01 % (full portfolio disclosed, September 2026)
- Mercer Passive Emerging Markets Equity Fund — Mercer · 0.01 % (full portfolio disclosed, December 2025)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.01 % (full portfolio disclosed, October 2026)